Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

3.21
-0.2787-7.99%
Volume:38.43K
Turnover:125.31K
Market Cap:4.77M
PE:-0.77
High:3.57
Open:3.49
Low:3.07
Close:3.49
Loading ...

Jefferies Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
17 Dec 2024

Evoke receives notice of allowance for two additional patent applications

TIPRANKS
·
03 Dec 2024

Evoke Pharma Inc: Two Patents Are Expected to Be Orange Book Listable and Expire at End of 2029

THOMSON REUTERS
·
03 Dec 2024

Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting Gimoti®

THOMSON REUTERS
·
03 Dec 2024

Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
10 Nov 2024

Evoke Pharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024

Evoke Pharma Q3 2024 GAAP EPS $(0.94) Misses $(0.38) Estimate, Sales $2.70M Miss $3.36M Estimate

Benzinga
·
08 Nov 2024

Evoke Pharma Inc Qtrly Net Loss Was Approximately $1.3 Million, or $0.94 per Share

THOMSON REUTERS
·
08 Nov 2024

Evoke Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit

Simply Wall St.
·
04 Nov 2024

S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings

Benzinga
·
29 Oct 2024

Evoke Pharma Shares Rise 70% on Gimoti Data in GLP-1 Users

Dow Jones
·
28 Oct 2024

Evoke stock rockets 90% on study of Gimoti in GLP-1 users

seekingalpha
·
28 Oct 2024

Evoke Pharma trading halted, volatility trading pause

TIPRANKS
·
28 Oct 2024

Evoke Pharma Shares More Than Double After Study Shows Potential of Co's Nasal Spray as Supportive Care for Glp-1 Therapy

THOMSON REUTERS
·
28 Oct 2024

Evoke Pharma Says Study Showed Gimoti Reduces Emergency Visits in Diabetic Gastroparesis Patients Using GLP-1; Shares Surge Pre-Bell

MT Newswires Live
·
28 Oct 2024